Skip to content
Dr. Grey AI

Condition

Hepatitis C

Hepatitis C is a viral infection of the liver that can cause ongoing inflammation and, over time, damage. Among supplements, TUDCA, a bile acid, has the most research behind it, and in one very small study of five people, liver cell content went up. That evidence is limited, and it shows nothing yet about the virus itself or how people felt, so the picture is still early.

Sources: PMID 8541578

Supplements studied
5
Medicines and peptides
1
Graded outcomes
3
Trials
5
People studied
661

Evidence by supplement

  • Strong
  • Moderate
  • Limited
  • Very limited

5 supplements

TUDCA: outcomes studied for Hepatitis C
GradeOutcomeEffectSizeStudiesPeopleStudies list
Liver Cell Content

Small Increase

Improves (the measure goes up)Small effect1 study5 people
Liver EnzymesChanges; see studies4 studies155 people
Black seed: outcomes studied for Hepatitis C
GradeOutcomeEffectSizeStudiesPeopleStudies list
Bilirubin

No effect

NoneNo effect30 people
Blood glucoseChanges; see studies2 studies30 people
Red Blood Cell CountImproves (the measure goes up)1 study30 people

Studies that measured red blood cell count

HCV Viral LoadImproves (the measure goes up)30 people
Liver EnzymesChanges; see studies30 people
Serum AlbuminImproves (the measure goes up)30 people
White Blood Cell CountImproves (the measure goes up)30 people

Silymarin

  • Liver Enzymes: changes; see studies
Silymarin: outcomes studied for Hepatitis C
GradeOutcomeEffectSizeStudiesPeopleStudies list
Liver EnzymesChanges; see studies6 studies202 people

S-adenosylmethionine

  • Early Virologic Response: improves
S-adenosylmethionine: outcomes studied for Hepatitis C
GradeOutcomeEffectSizeStudiesPeopleStudies list
Early Virologic ResponseImproves (the measure goes up)1 study21 people

Spirulina

  • HVC Viral Load: improves
Spirulina: outcomes studied for Hepatitis C
GradeOutcomeEffectSizeStudiesPeopleStudies list
HVC Viral LoadImproves (the measure goes up)1 study66 people

Prescription medicines and peptides studied, for context

These are not supplements. Most need a prescription, and some are research compounds with no approved use. They are listed so the supplement evidence above can be read against them.

1 medicine or peptide

Thymosin Alpha-1

  • Viral Load Reduction: improves
Thymosin Alpha-1: outcomes studied for Hepatitis C
GradeOutcomeEffectSizeStudiesPeopleStudies list
Viral Load Reduction

Small Decrease

Improves (the measure goes down)Small effect3 studies290 people

Key findings

  • Liver Cell ContentTUDCAImproves (the measure goes up)
  • BilirubinBlack seed

The Hepatitis C Supportive Care protocol

2 primary supplements · 3 supporting supplements

See the full protocol

Studies cited

100 studies from PubMed

  1. Thymosin alpha 1 alleviates inflammation and prevents infection in patients with severe acute pancreatitis through immune regulation: a systematic review and meta-analysis.Frontiers in immunology, 2025 · PMID 40599771
  2. The efficacy and safety of thymosin α1 for sepsis (TESTS): multicentre, double blinded, randomised, placebo controlled, phase 3 trial.BMJ (Clinical research ed.), 2025 · PMID 39814420
  3. The efficacy and safety of thymosin alpha-1 combined with lenvatinib plus sintilimab in unresectable hepatocellular carcinoma: a retrospective study.Scientific reports, 2025 · PMID 40263352
  4. PD-1 inhibitor combined with SBRT, GM-CSF, and thymosin alpha-1 in metastatic breast cancer: A case report and literature review.Medicine, 2024 · PMID 39183403
  5. Thymosin α1 reverses oncolytic adenovirus-induced M2 polarization of macrophages to improve antitumor immunity and therapeutic efficacy.Cell reports. Medicine, 2024 · PMID 39357524
  6. Thymosin Alpha 1 Plus Routine Treatment for the Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2024 · PMID 39648386
  7. Comprehensive Review of the Safety and Efficacy of Thymosin Alpha 1 in Human Clinical Trials.Alternative therapies in health and medicine, 2024 · PMID 38308608
  8. Thymosin α-1 in cancer therapy: Immunoregulation and potential applicationsInt Immunopharmacol, 2023 · PMID 36812669
  9. Thymosin alpha 1 - Reimagine its broader applications in the immuno-oncology eraInt Immunopharmacol, 2023 · PMID 36871535
  10. The efficacy of thymosin alpha-1 therapy in moderate to critical COVID-19 patients: a systematic review, meta-analysis, and meta-regression.Inflammopharmacology, 2023 · PMID 37845598
  11. Thymosin α-1 Reverses M2 Polarization of Tumor-Associated Macrophages during Efferocytosis.Cancer research, 2022 · PMID 35364609
  12. Thymosin alpha 1 as an adjuvant to hyperthermic intraperitoneal chemotherapy in an experimental model of peritoneal metastases from colonic carcinoma.International immunopharmacology, 2022 · PMID 35994852
  13. Thymosin alpha-1 therapy improves postoperative survival after curative resection for solitary hepatitis B virus-related hepatocellular carcinoma: A propensity score matching analysis.Medicine, 2021 · PMID 34011034
  14. Combination of Gemcitabine and Thymosin alpha 1 exhibit a better anti-tumor effect on nasal natural killer/T-cell lymphoma.International immunopharmacology, 2021 · PMID 34119916
  15. Thymosin alpha 1 exerts beneficial extrapulmonary effects in cystic fibrosis.European journal of medicinal chemistry, 2021 · PMID 33071052
  16. Effects of Nigella sativa on glycemic control, lipid profiles, and biomarkers of inflammatory and oxidative stress: A systematic review and meta-analysis of randomized controlled clinical trialsPhytother Res, 2020 · PMID 32394508
  17. Effects of spirulina and wakame consumption on intestinal cholesterol absorption and serum lipid concentrations in non-hypercholesterolemic adult men and womenEur J Nutr, 2020 · PMID 31388739
  18. Thymosin α1 therapy in critically ill patients with COVID-19: A multicenter retrospective cohort studyInt Immunopharmacol, 2020 · PMID 32795897
  19. Immunopotentiator thymosin alpha-1 attenuates inflammatory pain by modulating the Wnt3a/β-catenin pathway in spinal cord.Neuroreport, 2020 · PMID 31764244
  20. Thymosin Alpha 1 Reduces the Mortality of Severe Coronavirus Disease 2019 by Restoration of Lymphocytopenia and Reversion of Exhausted T Cells.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020 · PMID 32442287
  21. The clinical efficacy and adverse effects of Entecavir plus Thymosin alpha-1 combination therapy versus Entecavir Monotherapy in HBV-related cirrhosis: a systematic review and meta-analysis.BMC gastroenterology, 2020 · PMID 33076834
  22. Black Seed and Its Active Component Thymoquinone: Clinical ApplicationsPhytomedicine, 2019 · PMID 30506165
  23. Nigella sativa and Thymoquinone: A Therapeutic Promise for COVID-19 and BeyondPharmacol Res, 2019 · PMID 31162426
  24. Nigella sativa for Diabetes Management: A Review of Clinical StudiesPhytother Res, 2019 · PMID 30789225
  25. Safety and Efficacy of Nigella sativa in Clinical PracticeAvicenna J Phytomed, 2019 · PMID 30612116
  26. Spirulina in Health and Disease Prevention: A Comprehensive ReviewInt J Mol Sci, 2019 · PMID 30748114
  27. Thymosin alpha-1; a natural peptide inhibits cellular proliferation, cell migration, the level of reactive oxygen species and promotes the activity of antioxidant enzymes in human lung epithelial adenocarcinoma cell line (A549).Environmental toxicology, 2019 · PMID 31067016
  28. Thymosin Alpha-1 Inhibits Complete Freund's Adjuvant-Induced Pain and Production of Microglia-Mediated Pro-inflammatory Cytokines in Spinal Cord.Neuroscience bulletin, 2019 · PMID 30790216
  29. Antioxidant and angiotensin-converting enzyme (ACE) inhibitory activity of thymosin alpha-1 (Thα1) peptide.Bioorganic chemistry, 2019 · PMID 30974297
  30. Nigella sativa (Black Seed): A Comprehensive Review of Its Biological EffectsEvid Based Complement Alternat Med, 2018 · PMID 29885902
  31. Anti-Inflammatory Properties of Nigella sativa: A Systematic ReviewJ Ethnopharmacol, 2018 · PMID 29559206
  32. Nigella sativa (Black Seed) and Blood Pressure: A Comprehensive ReviewPhytother Res, 2018 · PMID 29516831
  33. Spirulina Supplementation and Metabolic Syndrome: A Meta-AnalysisPhytother Res, 2018 · PMID 29633990
  34. Spirulina and Allergic Rhinitis: A Systematic ReviewJ Med Food, 2018 · PMID 30315870
  35. Spirulina (Arthrospira): Nutritional Value and Health EffectsEvid Based Complement Alternat Med, 2018 · PMID 29405131
  36. Spirulina and Immune Function: A Systematic ReviewAutoimmun Rev, 2018 · PMID 30177301
  37. Safety Assessment of Spirulina (Arthrospira) as a Dietary SupplementComplement Ther Med, 2018 · PMID 29695109
  38. Thymosin alpha 1 treatment for patients with sepsisExpert Opin Biol Ther, 2018 · PMID 30063866
  39. Therapeutic Properties of Nigella sativa: A Clinical ReviewAsian Pac J Trop Biomed, 2017 · PMID 28068849
  40. Therapeutic Effects of Nigella sativa in Metabolic Syndrome: A ReviewPhytother Res, 2017 · PMID 28266363
  41. Antioxidant and Anti-Cancer Effects of Nigella sativa: Evidence from Clinical TrialsNutrients, 2017 · PMID 28326647
  42. A Systematic Review of the Effects of Spirulina on Cardiovascular Risk FactorsClin Nutr, 2017 · PMID 28182098
  43. Effects of Spirulina on Lipid Profile: A Systematic Review and Meta-AnalysisMedicine, 2017 · PMID 28849409
  44. Nigella sativa L. (Black Cumin): A Promising Natural Remedy for Wide Range of IllnessesEvid Based Complement Alternat Med, 2016 · PMID 27445889
  45. Antioxidant and Anti-Inflammatory Effects of Spirulina: Evidence from Clinical StudiesCardiovasc Ther, 2016 · PMID 27259333
  46. Effects of Spirulina on Body Weight and Blood Glucose: A Meta-AnalysisClin Nutr ESPEN, 2016 · PMID 27507219
  47. Immune Modulation with Thymosin Alpha 1 TreatmentVitam Horm, 2016 · PMID 27450734
  48. Thymosin alpha1 based immunomodulatory therapy for sepsis: a systematic review and meta-analysisInt J Infect Dis, 2015 · PMID 25532482
  49. Thymosin alpha-1 treatment in chronic hepatitis B.Expert opinion on biological therapy, 2015 · PMID 25640173
  50. Historical review of thymosin α 1 in infectious diseases.Expert opinion on biological therapy, 2015 · PMID 26098768
  51. Effect of Spirulina maxima on postprandial lipemia in young runners: a preliminary reportJ Med Food, 2012 · PMID 22738038
  52. Thymosin α1 and cancer: action on immune effector and tumor target cellsAnn N Y Acad Sci, 2012 · PMID 23045967
  53. Effect of thymosin alpha-1 on subpopulations of Th1, Th2, Th17, and regulatory T cells (Tregs) in vitroBraz J Med Biol Res, 2012 · PMID 22245858
  54. Thymosin-alpha 1 (Zadaxin) enhances the immunogenicity of an adjuvated pandemic H1N1v influenza vaccine (Focetria) in hemodialyzed patients: a pilot study.Vaccine, 2012 · PMID 22178096
  55. Thymosin alpha-1 with peginterferon alfa-2a/ribavirin for chronic hepatitis C not responsive to IFN/ribavirin: an adjuvant role?Journal of viral hepatitis, 2012 · PMID 22233415
  56. [Treatment with interferon and thymosin alpha-1 versus interferon monotherapy for HBeAg positive chronic hepatitis B: a meta-analysis].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2011 · PMID 21272455
  57. Utility of thymosin alpha-1 (Zadaxin) as a co-adjuvant in influenza vaccines: a review.Journal of preventive medicine and hygiene, 2011 · PMID 22010537
  58. Transcription profile of human lymphocytes following in vitro treatment with thymosin alpha-1.Annals of the New York Academy of Sciences, 2010 · PMID 20536445
  59. Thymosin alpha 1 for treatment of hepatitis C virus: promise and proof.Annals of the New York Academy of Sciences, 2010 · PMID 20536461
  60. Treatment with lamivudine versus lamivudine and thymosin alpha-1 for e antigen-positive chronic hepatitis B patients: a meta-analysis.Virology journal, 2009 · PMID 19467157
  61. Comparison of the efficacy of thymosin alpha-1 and interferon alpha in the treatment of chronic hepatitis B: a meta-analysis.Antiviral research, 2008 · PMID 18078676
  62. Wheat grass supplementation decreases oxidative stress in healthy subjects: a comparative study with spirulinaJ Altern Complement Med, 2007 · PMID 17983333
  63. Efficacy of thymosin alpha-1 and interferon alpha in treatment of chronic viral hepatitis B: a randomized controlled study.World journal of gastroenterology, 2006 · PMID 17075991
  64. Thymalfasin (thymosin-alpha 1) therapy in patients with chronic hepatitis B.Journal of gastroenterology and hepatology, 2004 · PMID 15546254
  65. Thymalfasin (thymosin-alpha 1) therapy in patients with chronic hepatitis B.Journal of gastroenterology and hepatology, 2004 · PMID 15641208
  66. Thymosin alpha(1) in combination with cytokines and chemotherapy for the treatment of cancer.International immunopharmacology, 2003 · PMID 12860169
  67. Thymosin alpha-1Am J Health Syst Pharm, 2001 · PMID 11381492
  68. Thymosin alpha 1 in the treatment of cancer: from basic research to clinical applicationInt J Immunopharmacol, 2000 · PMID 11137613
  69. Thymosin alpha1 treatment of chronic hepatitis B: results of a phase III multicentre, randomized, double-blind and placebo-controlled studyJ Viral Hepat, 1999 · PMID 10607256
  70. Efficacy of thymosin alpha1 in patients with chronic hepatitis B: a randomized, controlled trialHepatology, 1998 · PMID 9581695
  71. Thymosin alpha 1 antagonizes dexamethasone and CD3-induced apoptosis of CD4+ CD8+ thymocytes through the activation of cAMP and protein kinase C dependent second messenger pathways.Mechanisms of ageing and development, 1997 · PMID 9147362
  72. Thymosin alpha 1 protects liver and aorta from oxidative damage in atherosclerotic rabbits.Life sciences, 1996 · PMID 8809225
  73. Thymosin alpha 1 effects, in vitro, on lymphokine-activated killer cells from patients with primary immunodeficiencies: preliminary results.International journal of immunopharmacology, 1994 · PMID 7705963
  74. Thymosin alpha-1 as adjunct for conventional therapy of malignant tumors: a review.Cancer investigation, 1994 · PMID 7922706
  75. Thymosin alpha 1 and thymosin beta 4 modulate human colonic lamina propria lymphocyte function.Immunopharmacology, 1990 · PMID 2266003
  76. Thymosin alpha 1 modulates the expression of high affinity interleukin-2 receptors on normal human lymphocytes.International journal of immunopharmacology, 1990 · PMID 2303316
  77. A radioimmunoassay for thymosin alpha-1.Journal of immunological methods, 1986 · PMID 3701071
  78. Thymosin alpha 1-induced modulation of cellular responses and functional T-cell subsets in mice with experimental autoimmune thyroiditis.Cellular immunology, 1985 · PMID 3873993
  79. Thymosin alpha 1 restores NK-cell activity and prevents tumor progression in mice immunosuppressed by cytostatics or X-rays.Cancer immunology, immunotherapy : CII, 1983 · PMID 6553515
  80. Immunochemical studies on thymosin: radioimmunoassay of thymosin alpha 1.Journal of immunology (Baltimore, Md. : 1950), 1982 · PMID 7054279
  81. Effectiveness, safety, and tolerability of powdered Nigella sativa (kalonji) seed in capsules on serum lipid levels, blood sugar, blood pressure, and body weight in adults: results of a randomized, double-blind controlled trialJ Altern Complement Med · PMID 19500003
  82. Antihypertensive effects of Nigella sativa supplementation: An updated systematic review and meta-analysis of randomized controlled trials.Phytother Res · PMID 37341696
  83. Endothelial Function Responses to Nigella sativa (Black Seed) Supplementation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Cureus · PMID 38915995
  84. The effect of Nigella sativa Linn. seed on memory, attention and cognition in healthy human volunteersJ Ethnopharmacol · PMID 23707331
  85. Efficacy of Nigella sativa on serum free testosterone and metabolic disturbances in central obese maleActa Med Indones · PMID 20724766
  86. Potential adjuvant effects of Nigella sativa seeds to improve specific immunotherapy in allergic rhinitis patientsMed Princ Pract · PMID 20357504
  87. Effect of Nigella sativa (black seed) on subjective feeling in patients with allergic diseasesPhytother Res · PMID 14669258
  88. Herbal treatment of allergic rhinitis: the use of Nigella sativaAm J Otolaryngol · PMID 20947211
  89. Clinical evaluation of Nigella sativa seeds for the treatment of hyperlipidemia: a randomized, placebo controlled clinical trialMed Arh · PMID 22822623
  90. The possible prophylactic effect of Nigella sativa seed extract in asthmatic patientsFundam Clin Pharmacol · PMID 17868210
  91. Antihypertensive effect of Nigella sativa seed extract in patients with mild hypertensionFundam Clin Pharmacol · PMID 18705755
  92. Effects of Nigella sativa on outcome of hepatitis C in EgyptWorld J Gastroenterol · PMID 23674855
  93. Effectiveness of Nigella sativa oil in the management of rheumatoid arthritis patients: a placebo controlled studyPhytother Res · PMID 22162258
  94. Effect of Nigella sativa seeds on the glycemic control of patients with type 2 diabetes mellitusIndian J Physiol Pharmacol · PMID 21675032
  95. supplementation improves cardiometabolic indicators in population with prediabetes and type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials.Front Nutr · PMID 36034891
  96. The effect of Nigella sativa (black seed) on biomarkers of inflammation and oxidative stress: an updated systematic review and meta-analysis of randomized controlled trials.Inflammopharmacology · PMID 37036558
  97. The possible prophylactic effect of Nigella sativa seed aqueous extract on respiratory symptoms and pulmonary function tests on chemical war victims: a randomized, double-blind, placebo-controlled trialJ Altern Complement Med · PMID 18991514
  98. Effect of Nigella sativa Consumption on Lipid Profile and Glycemic Index in Patients with Metabolic Syndrome: A Systematic Review and Meta-analysis of Randomized Controlled Trials.Curr Med Chem · PMID 38265398
  99. Effect of Nigella sativa oil on various clinical and biochemical parameters of insulin resistance syndromeInt J Diabetes Dev Ctries · PMID 19902033
  100. The effect of thymoquinone on intractable pediatric seizures (pilot study)Epilepsy Res · PMID 21112742